GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Capital Expenditure

IMGT (XKRX:456570) Capital Expenditure : ₩-227.89 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

IMGT's cash flow for capital expenditures for the six months ended in Dec. 2024 was ₩-227.89 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-227.89 Mil.

IMGT Capital Expenditure Historical Data

The historical data trend for IMGT's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Capital Expenditure Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
-281.84 -1,668.81 -359.74 -478.38 -227.89

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure -281.84 -1,668.81 -359.74 -478.38 -227.89

IMGT Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-227.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMGT Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Capital Expenditure
Comparable Companies
XKRX:308080 XKRX:383930 XKRX:388610 XKRX:142760 XKRX:365270 XKRX:032790 XKRX:038070 XKRX:263050 XKRX:225220 XKRX:389030 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines